Pipeline

Our Innovative Project Pipeline

An innovative project pipeline aiming disease modifying principles for successfully treating human brain diseases. Our programs have identified new small molecules active in key biological targets involved in neurological diseases.

Our current pipeline progress successfully towards new medicinal principles for the treatment of Parkinson’s disease and epilepsy.

Projects in pipeline :

4

ABXY-1

Hit-to-Lead

ABXY-2

Discovery-POC

ABXY-3

Advanced Lead Optimization

ABXY-4

Discovery

Next generation disease modifying medicines

Our pipeline is combines innovative early preclinical and advanced programs aiming neurodegenerative diseases. Looking ahead to horizon 2022, our programs aim to reach pre-IND (ABXY-3) and lead candidate selection (ABXY-1) phases. ABXY-3 intends to get approval for an orphan indication of the Parkinson’s disease spectrum.

Aiming to provide innovation to brain diseases and addressing their huge unmet medical needs, we have 2 more programs ABXY-1002 and ABXY-4 that are successfully advancing to entry in preclinical development

looking ahead to future neurotherapeutics